Thrombogenic Risk Induced by Intravascular Mesenchymal Stem Cell Therapy: Current Status and Future Perspectives

Mesenchymal stem cells (MSCs) are currently studied and used in numerous clinical trials. Nevertheless, some concerns have been raised regarding the safety of these infusions and the thrombogenic risk they induce. MSCs express procoagulant activity (PCA) linked to the expression of tissue factor (TF...

Descripción completa

Detalles Bibliográficos
Autores principales: Coppin, Louise, Sokal, Etienne, Stéphenne, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829440/
https://www.ncbi.nlm.nih.gov/pubmed/31569696
http://dx.doi.org/10.3390/cells8101160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829440/
https://www.ncbi.nlm.nih.gov/pubmed/31569696
http://dx.doi.org/10.3390/cells8101160

Ejemplares similares